Académique Documents
Professionnel Documents
Culture Documents
Retail
Wednesday 22 Feb 2017
Choosing Wisely
abstracts sought
EBOS net profit up 10.9% New orphan drug
THE Therapeutic Goods
EBOS this morning reported its The groups Consumer Products Administration has added riluzole
NPS MedicineWise is inviting
results for the six months to 31 division saw revenue surge 58% (Teglutik) from Seqirus to its list of
health professionals to submit
Dec, with net profit after tax rising year-on-year, with a full six month designated orphan drugs.
abstracts for the inaugural
10.9% to NZ$68.8 million. contribution from Red Seal which Teglutik is a liquid oral suspension
Choosing Wisely Australia National
The company said its Australian was acquired on 30 Nov 2015. used for the treatment of patients
Meeting 2017.
revenues climbed 27%, resulting in Davies said EBOS was continuing with amyotrophic lateral sclerosis,
To be held in Melbourne on
EBITDA growth of 11%. to invest in its healthcare also known as ALS.
Thu 04 May, the event aims to
The increased sales were driven businesses, citing the completion of
showcase the implementation
by the full six months of trading for the Terry White Chemmart merger Virus delivery method
of the Choosing Wisely Australia
the new Hepatitis C medicines. in the first half.
initiative across the health sector RESEARCHERS at the University
In the Australian pharmacy This merger has created one of
and among consumers since its of Queenslands Australian
market, wholesale revenue growth Australias largest retail pharmacy
launch in Apr 2015. Institute for Bioengineering and
(excluding Hepatitis C medicines) networks that is well placed for
The National Meeting will Nanotechnology have developed
was affected by the ongoing impact growth and future opportunities
also look at future activities as a virus-like nanoparticle (VNP)
of PBS reforms and lower levels that emerge in the retail pharamcy
momentum continues to build which delivers chemotherapy drugs
of activity in the non-prescription sector, he commented.
around the Choosing Wisely directly to cells where they are
over-the counter (OTC) channel, Other investments in the EBOS
approach, which has now been needed in the battle against cancer.
said EBOS Group ceo Patrick Davies. operational capacity include the
adopted in 17 countries. The VNP is an empty shell...
However the companys $58m new wholesale distribution
Choosing Wisely aims to eliminate it looks like a virus but its not
Healthcare division continues to facility in Brisbane, and the
unnecessary tests, treatments infections, said Dr Frank Sainsbury,
offset the negative impact of PBS development of a new contract
and procedures using the latest lead author of a paper on the topic.
reforms by expanding its revenue logistics site in Sydney.
evidence-based recommendations That makes it safe to use as a
streams and generating cost savings EBOS said it expects its full year
from Australias specialist medical targeted drug delivery system.
and improved productivity across FY17 earnings to be close to 10%
colleges, societies and associations. He said the research unlocked a
its operations, he added. higher than the prior year.
This event is a great opportunity myriad of potential applications in
for Choosing Wisely Australia therapeutic delivery - to view the
stakeholders to engage in
conversations around best
Chemist Warehouse makes scents paper see pub.acs.org.
Pharmacy Daily Wednesday 22nd February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
Follow us
on social media
Just one click away from keeping up
to date with all the Pharmacy Daily
Wednesday 22 Feb 2017 breaking news as it comes to hand
TRANSFORM
YOUR PHARMACY
Preview the transformation
solution at our APP stand
+ Valuable coaching
+ Comprehensive tools and resources
+ Proven results
Were here to support your
pharmacys transformation VISIT STAND 911
Pharmacy Daily Wednesday 22nd February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2
Do you have the Pharmacy
Daily app?
Dispensary
Health, Beauty
Welcome to our weekly promoted
feature with all the latest health,
Corner beauty and new products for pharmacy.
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Nathalie Craig, Jasmine ODonoghue, Bonnie Tai
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Wednesday 22nd February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 3